CBIO

Crescent Biopharma, Inc. Common Stock

34 hedge funds and large institutions have $6.46M invested in Crescent Biopharma, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 12 closing their positions.

Holders
34
Holders Change
-7
Holders Change %
-17.07%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
5
Reduced
7
Closed
12
Calls
$24K
Puts
$52K
Net Calls
-$28K
Net Calls Change
-$54K
Name Market Value Shares Shares
Change
Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$1.96K 9,353 -10,206 -52%
SS
27
SBI Securities
Japan
$1.46K 6,942
Morgan Stanley
28
Morgan Stanley
New York
$1.09K 5,176
TC
29
Truvestments Capital
Florida
$275 1,309
Bank of America
30
Bank of America
North Carolina
$165 787 +26 +3%
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$101 481
JPMorgan Chase & Co
32
JPMorgan Chase & Co
New York
$26 126 -10 -7%
ACM
33
ADAR1 Capital Management
Texas
-331,827 Closed
CC
34
Caxton Corporation
New Jersey
-203,578 Closed
XT
35
XTX Topco
Cayman Islands
-64,243 Closed
Jane Street
36
Jane Street
New York
-58,854 Closed
Renaissance Technologies
37
Renaissance Technologies
New York
-41,153 Closed
GSC
38
Ground Swell Capital
South Carolina
-33,230 Closed
BBA
39
Baader Bank Aktiengesellschaft
Germany
-13,966 Closed
CSS
40
Cubist Systematic Strategies
Connecticut
-13,760 Closed
HSA
41
HBK Sorce Advisory
Pennsylvania
-11,718 Closed
IC
42
Ikarian Capital
Texas
-6,501 Closed
EWA
43
EverSource Wealth Advisors
Alabama
-4,755 Closed
Acadian Asset Management
44
Acadian Asset Management
Massachusetts
-1,096 Closed
Citadel Advisors
45
Citadel Advisors
Florida
Simplex Trading
46
Simplex Trading
Illinois
CFGS
47
Concourse Financial Group Securities
Alabama
Barclays
48
Barclays
United Kingdom
$0 76
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$0 2,000